Max Nieuwdorp

Active 2005–2026

257
Papers
37,044
Citations
88
h-index
229
i10-index

Citations

Citations per year for Max Nieuwdorp1971: 1 citations1989: 2 citations1991: 1 citations1995: 2 citations1998: 1 citations2000: 1 citations2002: 1 citations2005: 2 citations2006: 20 citations2007: 36 citations2008: 47 citations2009: 33 citations2010: 57 citations2011: 68 citations2012: 77 citations2013: 201 citations2014: 307 citations2015: 318 citations2016: 417 citations2017: 484 citations2018: 548 citations2019: 1,381 citations2020: 1,929 citations2021: 2,162 citations2022: 2,230 citations2023: 1,924 citations2024: 2,913 citations2025: 1,874 citations2026: 51 citations1972–1988: no citations, so these years are not shown1990: no citations, so this year is not shown1992–1994: no citations, so these years are not shown1996–1997: no citations, so these years are not shown1999: no citations, so this year is not shown2001: no citations, so this year is not shown2003–2004: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,617 citing papers, 18.3% of this breakdownUnited States: 3,543 citing papers, 18% of this breakdownUnited Kingdom: 964 citing papers, 4.9% of this breakdownNetherlands: 930 citing papers, 4.7% of this breakdownItaly: 906 citing papers, 4.6% of this breakdownGermany: 801 citing papers, 4.1% of this breakdownCanada: 616 citing papers, 3.1% of this breakdownFrance: 554 citing papers, 2.8% of this breakdownAustralia: 545 citing papers, 2.8% of this breakdownSpain: 519 citing papers, 2.6% of this breakdownJapan: 405 citing papers, 2.1% of this breakdownDenmark: 397 citing papers, 2% of this breakdown
0%18.3%Other 30%

Fields

  • Medicine45.6%
  • Biochemistry, Genetics and Molecular Biology42.5%
  • Immunology and Microbiology2.4%
  • Agricultural and Biological Sciences2.1%
  • Neuroscience1.8%
  • Nursing1.7%
  • Other3.9%

Topics

  • Gut microbiota and health18.3%
  • Diet and metabolism studies6.8%
  • Clostridium difficile and Clostridium perfringens research6.6%
  • Liver Disease Diagnosis and Treatment4%
  • Gastrointestinal motility and disorders3.2%
  • Probiotics and Fermented Foods2.2%
  • Other58.9%

Coauthors

All papers

Open in search
  1. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

    Authors: , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2020 cited by 1,043

  2. Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 3,673

  3. Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2012 cited by 2,850

  4. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes

    Authors: , , , , , , - Frontiers in Immunology 2020 cited by 653

  5. Gut microbiome-wide association study of depressive symptoms

    Authors: , , , , , , , , , , , - Nature Communications 2022 cited by 434

  6. European consensus conference on faecal microbiota transplantation in clinical practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2017 cited by 1,155

  7. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2017 cited by 1,008

  8. Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1

    Authors: , , , , , , , , , , , , , , , , , - Cell 2018 cited by 837

  9. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies

    Authors: , , , - Gastroenterology 2020 cited by 435

  10. Drivers and determinants of strain dynamics following fecal microbiota transplantation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 218

  11. Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2016 cited by 656

  12. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 485

  13. Microbiome-derived ethanol in nonalcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 202

  14. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 745

  15. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , F. Holleman, Lorenzo Piemonti, Willem M. de Vos, Bart O. Roep, Max Nieuwdorp - Gut 2020 cited by 305

  16. Gut Microbiota in Hypertension and Atherosclerosis: A Review

    Authors: , , , - Nutrients 2020 cited by 388

  17. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas and 130 more - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 187

  18. Gut Microbiota Composition Is Related to AD Pathology

    Authors: , , , , , , , , , , , , - Frontiers in Immunology 2022 cited by 221

  19. Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?

    Authors: , , , - Gastroenterology 2020 cited by 233

  20. Therapeutic Potential of Fecal Microbiota Transplantation

    Authors: , , , , - Gastroenterology 2013 cited by 742

  21. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta B. Afonso, Ramy Younes, Yuichiro Amano, Scott L. Friedman, Shuang Wang, Dipankar Bhattacharya, Eric J. Simon, Valérie Paradis, Alastair D. Burt, Ioanna Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Elisabeth Pors, M Andersen, Michael Feigh, Carla Yunis, Pierre Bédossa, Michelle Stewart, Heather Cater, Sara Wells, Jörn M. Schattenberg, Quentin M. Anstee, The LITMUS Investigators, Quentin M. Anstee, Ann K. Daly, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Jo Boyle, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Yong Ook Kim, Beate K. Straub, Antonio Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Mark Campbell, Chris Lelliott, Susan Davies, Matej Orešič, Tuulia Hyötyläinen and 138 more - Nature Metabolism 2024 cited by 229

  22. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 302

  23. Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 278

  24. Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology Communications 2020 cited by 143